+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Transplant Diagnostics Market Forecast to 2033- Product Image
Transplant Diagnostics Market Forecast to 2033- Product Image
New

Transplant Diagnostics Market Forecast to 2033

  • PDF Icon

    Report

  • 150 Pages
  • October 2025
  • Region: Global
  • Grand View Research
  • ID: 5999020
REQUEST CUSTOMIZATION
Description Jump to:
The global transplant diagnostics market size was estimated at USD 6.39 billion in 2024 and is expected to reach USD 12.15 billion in 2033, growing at a CAGR of 7.45% from 2025 to 2033. The rising prevalence of genetic disorders, technological advancements in genetic testing, and growing awareness and demand for personalized medicine are boosting the market growth.

For instance, in October 2025, UBC enzyme technology introduced the first human test toward universal donor organs for transplantation. It has developed enzymes that successfully convert a kidney to universal type O for transplant, marking a significant step toward faster, more compatible organ donations. Further, the results show that the kidney functioned normally for two days without evidence of hyperacute rejection. This quick immune reaction can destroy an incompatible organ in minutes. By the third day, some blood-type markers resurfaced, causing a moderate response. Still, the damage was significantly less severe than in a usual mismatch, and researchers noticed signals that the body was starting to tolerate the organ.

Furthermore, the aging population, the prevalence of chronic disease, and advances in transplantation techniques are all driving market growth. For example, in October 2025, the World Health Organization claimed that in 2020, individuals aged 60 and older outnumbered children under five. Between 2015 and 2050, the worldwide population over 60 will almost double, from 12% to 22%. Furthermore, by 2050, 80% of older people will reside in low- and middle-income countries. The pace of population ageing is much faster than in the past. As chronic diseases such as heart failure, kidney disease, and liver disorders continue to rise, the need for organ transplantation as a life-saving treatment is also increasing. This rise in transplant procedures highlights the importance of accurate and advanced diagnostic tools to ensure donor-recipient compatibility, reduce the risk of organ rejection, and improve transplantation success rates.

Global Transplant Diagnostics Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global transplant diagnostics market report based on test, product, application, transplant area, end-use, and region:

Test Outlook (Revenue, USD Million, 2021-2033)

  • PCR-based Molecular Assays
  • Real-time PCR
  • Sequence-based Primer-PCR
  • Sequence-specific Oligonucleotide-PCR
  • Other PCR-based Molecular Assays
  • Sanger Sequencing
  • Next Generation Sequencing
  • Other Sequencing-based Molecular Assays
  • Serological Assays
  • Mixed Lymphocyte Culture Assays

Product Outlook (Revenue, USD Million, 2021-2033)

Application Outlook (Revenue, USD Million, 2021-2033)

  • Infectious Disease Testing
  • Histocompatibility Testing
  • Blood Profiling

Transplant Area Outlook (Revenue, USD Million, 2021-2033)

  • Kidney Transplantation
  • Liver Transplantation
  • Heart Transplantation
  • Lung Transplantation
  • Pancreas Transplantation
  • Other Organs Transplantation

End-use Outlook (Revenue, USD Million, 2021-2033)

Regional Outlook (Revenue, USD Million, 2021-2033)

  • U.S.
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

Report Deliverables

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Transplant Diagnostics Market: Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Test
1.1.1.2. Product Segment
1.1.1.3. Application Segment
1.1.1.4. Transplant Area Segment
1.1.1.5. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Transplant Diagnostics Market: Executive Summary
2.1. Market Snapshot
2.2. Test
2.3. Product Snapshot
2.4. Application Snapshot
2.5. Transplant Area Snapshot
2.6. End Use Snapshot
2.7. Competitive Landscape Snapshot
Chapter 3. Transplant Diagnostics Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers Analysis
3.4.1. Rising prevalence of genetic disorders
3.4.2. Technological advancements in genetic testing
3.4.3. Growing awareness and demand for personalized medicine
3.5. Market Restraint Analysis
3.5.1. Limited implementation of public health screening
3.6. Porter’s Five Forces Analysis
3.7. PESTLE Analysis
3.8. Pipeline Analysis
Chapter 4. Transplant Diagnostics Market: Test Estimates & Trend Analysis
4.1. Transplant Diagnostics Market: Test Movement Analysis
4.2. Molecular Assays
4.2.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.2.2. PCR-based Molecular Assays
4.2.2.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.2.3. Real-time PCR
4.2.3.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.2.4. Sequence-based Primer-PCR
4.2.4.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.2.5. Sequence-specific Oligonucleotide-PCR
4.2.6. Other PCR-based Molecular Assays
4.2.6.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3. Sequencing-based Molecular Assays
4.3.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2. Sanger Sequencing
4.3.2.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3. Next Generation Sequencing
4.3.3.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.4. Other Sequencing-based Molecular Assays
4.3.4.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4. Non-molecular Assays
4.4.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2. Serological Assays
4.4.2.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3. Mixed Lymphocyte Culture Assays
4.4.3.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. Transplant Diagnostics Market: Product Estimates & Trend Analysis
5.1. Transplant Diagnostics Market: Product Movement Analysis
5.2. Reagents & Consumables
5.2.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.3. Instruments
5.3.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.4. Software and Services
5.4.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. Transplant Diagnostics Market: Application Estimates & Trend Analysis
6.1. Transplant Diagnostics Market: Application Movement Analysis
6.2. Diagnostic Application
6.2.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.2.2. Infectious Disease Testing
6.2.2.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
6.2.3. Histocompatibility Testing
6.2.3.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
6.2.4. Blood Profiling
6.3. Research Application
6.3.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. Transplant Diagnostics Market: Transplant Area Estimates & Trend Analysis
7.1. Transplant Diagnostics Market: Transplant Area Movement Analysis
7.2. Solid Area Transplantation
7.2.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
7.2.2. Kidney Transplantation
7.2.2.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
7.2.3. Liver Transplantation
7.2.3.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
7.2.4. Heart Transplantation
7.2.4.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
7.2.5. Lung Transplantation
7.2.5.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
7.2.6. Pancreas Transplantation
7.2.6.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
7.2.7. Other Organs Transplantation
7.2.7.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
7.3. Stem Cell Transplantation
7.3.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
7.3.2. Soft Tissue Transplantation
7.3.2.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
7.3.3. Bone Marrow Transplantation
7.3.3.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 8. Transplant Diagnostics Market: End Use Estimates & Trend Analysis
8.1. Transplant Diagnostics Market: End Use Movement Analysis
8.2. Hospitals and Transplant Centers
8.2.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
8.3. Research and Academic Institutes
8.3.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
8.4. Independent Reference Laboratories
8.4.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 9. Transplant Diagnostics Market: Regional Business Analysis
9.1. Regional Market Snapshot
9.2. North America
9.2.1. North America Transplant Diagnostics Market Estimates and Forecast, 2021-2033 (USD Million)
9.2.2. U.S.
9.2.2.1. U.S. Transplant Diagnostics Market, 2021-2033 (USD Million)
9.2.2.2. Key Country Dynamics
9.2.2.3. Regulatory Framework
9.2.2.4. Reimbursement Scenario
9.2.2.5. Competitive Scenario
9.2.3. Canada
9.2.3.1. Canada Transplant Diagnostics Market, 2021-2033 (USD Million)
9.2.3.2. Key Country Dynamics
9.2.3.3. Regulatory Framework
9.2.3.4. Reimbursement Scenario
9.2.3.5. Competitive Scenario
9.2.4. Mexico
9.2.4.1. Mexico Transplant Diagnostics Market, 2021-2033 (USD Million)
9.2.4.2. Key Country Dynamics
9.2.4.3. Regulatory Framework
9.2.4.4. Reimbursement Scenario
9.2.4.5. Competitive Scenario
9.3. Europe
9.3.1. Europe Transplant Diagnostics Market, 2021-2033 (USD Million)
9.3.2. UK
9.3.2.1. UK Transplant Diagnostics Market, 2021-2033 (USD Million)
9.3.2.2. Key Country Dynamics
9.3.2.3. Regulatory Framework
9.3.2.4. Reimbursement Scenario
9.3.2.5. Competitive Scenario
9.3.3. Germany
9.3.3.1. Germany Transplant Diagnostics Market, 2021-2033 (USD Million)
9.3.3.2. Key Country Dynamics
9.3.3.3. Regulatory Framework
9.3.3.4. Reimbursement Scenario
9.3.3.5. Competitive Scenario
9.3.4. Spain
9.3.4.1. Spain Transplant Diagnostics Market, 2021-2033 (USD Million)
9.3.4.2. Key Country Dynamics
9.3.4.3. Regulatory Framework
9.3.4.4. Reimbursement Scenario
9.3.4.5. Competitive Scenario
9.3.5. France
9.3.5.1. France Transplant Diagnostics Market, 2021-2033 (USD Million)
9.3.5.2. Key Country Dynamics
9.3.5.3. Regulatory Framework
9.3.5.4. Reimbursement Scenario
9.3.5.5. Competitive Scenario
9.3.6. Italy
9.3.6.1. Italy Transplant Diagnostics Market, 2021-2033 (USD Million)
9.3.6.2. Key Country Dynamics
9.3.6.3. Regulatory Framework
9.3.6.4. Reimbursement Scenario
9.3.6.5. Competitive Scenario
9.3.7. Denmark
9.3.7.1. Denmark Transplant Diagnostics Market, 2021-2033 (USD Million)
9.3.7.2. Key Country Dynamics
9.3.7.3. Regulatory Framework
9.3.7.4. Reimbursement Scenario
9.3.7.5. Competitive Scenario
9.3.8. Sweden
9.3.8.1. Sweden Transplant Diagnostics Market, 2021-2033 (USD Million)
9.3.8.2. Key Country Dynamics
9.3.8.3. Regulatory Framework
9.3.8.4. Reimbursement Scenario
9.3.8.5. Competitive Scenario
9.3.9. Norway
9.3.9.1. Norway Transplant Diagnostics Market, 2021-2033 (USD Million)
9.3.9.2. Key Country Dynamics
9.3.9.3. Regulatory Framework
9.3.9.4. Reimbursement Scenario
9.3.9.5. Competitive Scenario
9.4. Asia Pacific
9.4.1. Asia-Pacific Transplant Diagnostics Market, 2021-2033 (USD Million)
9.4.2. Japan
9.4.2.1. Japan Transplant Diagnostics Market, 2021-2033 (USD Million)
9.4.2.2. Key Country Dynamics
9.4.2.3. Regulatory Framework
9.4.2.4. Reimbursement Scenario
9.4.2.5. Competitive Scenario
9.4.3. China
9.4.3.1. China Transplant Diagnostics Market, 2021-2033 (USD Million)
9.4.3.2. Key Country Dynamics
9.4.3.3. Regulatory Framework
9.4.3.4. Reimbursement Scenario
9.4.3.5. Competitive Scenario
9.4.4. India
9.4.4.1. India Transplant Diagnostics Market, 2021-2033 (USD Million)
9.4.4.2. Key Country Dynamics
9.4.4.3. Regulatory Framework
9.4.4.4. Reimbursement Scenario
9.4.4.5. Competitive Scenario
9.4.5. South Korea
9.4.5.1. South Korea Transplant Diagnostics Market, 2021-2033 (USD Million)
9.4.5.2. Key Country Dynamics
9.4.5.3. Regulatory Framework
9.4.5.4. Reimbursement Scenario
9.4.5.5. Competitive Scenario
9.4.6. Thailand
9.4.6.1. Thailand Transplant Diagnostics Market, 2021-2033 (USD Million)
9.4.6.2. Key Country Dynamics
9.4.6.3. Regulatory Framework
9.4.6.4. Reimbursement Scenario
9.4.6.5. Competitive Scenario
9.4.7. Australia
9.4.7.1. Australia Transplant Diagnostics Market, 2021-2033 (USD Million)
9.4.7.2. Key Country Dynamics
9.4.7.3. Regulatory Framework
9.4.7.4. Reimbursement Scenario
9.4.7.5. Competitive Scenario
9.5. Latin America
9.5.1. Latin America Transplant Diagnostics Market, 2021-2033 (USD Million)
9.5.2. Brazil
9.5.2.1. Brazil Transplant Diagnostics Market, 2021-2033 (USD Million)
9.5.2.2. Key Country Dynamics
9.5.2.3. Regulatory Framework
9.5.2.4. Reimbursement Scenario
9.5.2.5. Competitive Scenario
9.5.3. Argentina
9.5.3.1. Argentina Transplant Diagnostics Market, 2021-2033 (USD Million)
9.5.3.2. Key Country Dynamics
9.5.3.3. Regulatory Framework
9.5.3.4. Reimbursement Scenario
9.5.3.5. Competitive Scenario
9.6. MEA
9.6.1. MEA Transplant Diagnostics Market, 2021-2033 (USD Million)
9.6.2. South Africa
9.6.2.1. South Africa Transplant Diagnostics Market, 2021-2033 (USD Million)
9.6.2.2. Key Country Dynamics
9.6.2.3. Regulatory Framework
9.6.2.4. Reimbursement Scenario
9.6.2.5. Competitive Scenario
9.6.3. Saudi Arabia
9.6.3.1. Saudi Arabia Transplant Diagnostics Market, 2021-2033 (USD Million)
9.6.3.2. Key Country Dynamics
9.6.3.3. Regulatory Framework
9.6.3.4. Reimbursement Scenario
9.6.3.5. Competitive Scenario
9.6.4. UAE
9.6.4.1. UAE Transplant Diagnostics Market, 2021-2033 (USD Million)
9.6.4.2. Key Country Dynamics
9.6.4.3. Regulatory Framework
9.6.4.4. Reimbursement Scenario
9.6.4.5. Competitive Scenario
9.6.5. Kuwait
9.6.5.1. Kuwait Transplant Diagnostics Market, 2021-2033 (USD Million)
9.6.5.2. Key Country Dynamics
9.6.5.3. Regulatory Framework
9.6.5.4. Reimbursement Scenario
9.6.5.5. Competitive Scenario
Chapter 10. Competitive Landscape
10.1. Company Categorization
10.2. Strategy Mapping
10.2.1. New product launch
10.2.2. Partnerships
10.2.3. Acquisition
10.2.4. Collaboration
10.2.5. Funding
10.3. Key Company Market Share Analysis, 2024
10.4. Company Heat Map Analysis
10.5. Company Profiles
10.5.1. Thermo Fisher Scientific, Inc.
10.5.1.1. Company Overview
10.5.1.2. Financial Performance
10.5.1.3. Product Benchmarking
10.5.1.4. Strategic Initiatives
10.5.2. Illumina, Inc.
10.5.2.1. Company Overview
10.5.2.2. Financial Performance
10.5.2.3. Product Benchmarking
10.5.2.4. Strategic Initiatives
10.5.3. F. Hoffmann La-Roche Ltd
10.5.3.1. Company Overview
10.5.3.2. Financial Performance
10.5.3.3. Product Benchmarking
10.5.3.4. Strategic Initiatives
10.5.4. Abbott
10.5.4.1. Company Overview
10.5.4.2. Financial Performance
10.5.4.3. Product Benchmarking
10.5.4.4. Strategic Initiatives
10.5.5. QIAGEN
10.5.5.1. Company Overview
10.5.5.2. Financial Performance
10.5.5.3. Product Benchmarking
10.5.5.4. Strategic Initiatives
10.5.6. Bruker
10.5.6.1. Company Overview
10.5.6.2. Financial Performance
10.5.6.3. Product Benchmarking
10.5.6.4. Strategic Initiatives
10.5.7. BD (Becton, Dickinson and Company)
10.5.7.1. Company Overview
10.5.7.2. Financial Performance
10.5.7.3. Product Benchmarking
10.5.7.4. Strategic Initiatives
10.5.8. Werfen (Immucor, Inc.)
10.5.8.1. Company Overview
10.5.8.2. Financial Performance
10.5.8.3. Product Benchmarking
10.5.8.4. Strategic Initiatives
10.5.9. Bio-Rad Laboratories, Inc.
10.5.9.1. Company Overview
10.5.9.2. Financial Performance
10.5.9.3. Product Benchmarking
10.5.9.4. Strategic Initiatives
10.5.10. Omixon Inc.
10.5.10.1. Company Overview
10.5.10.2. Financial Performance
10.5.10.3. Product Benchmarking
10.5.10.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Transplant Diagnostics Market, by Region, 2021-2033 (USD Million)
Table 4 Global Transplant Diagnostics Market, by Test, 2021-2033 (USD Million)
Table 5 Global Transplant Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 6 Global Transplant Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 7 Global Transplant Diagnostics Market, by Therapeutic Area, 2021-2033 (USD Million)
Table 8 Global Transplant Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 9 North America Transplant Diagnostics Market, by Country, 2021-2033 (USD Million)
Table 10 North America Transplant Diagnostics Market, by Test, 2021-2033 (USD Million)
Table 11 North America Transplant Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 12 North America Transplant Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 13 North America Transplant Diagnostics Market, by Therapeutic Area, 2021-2033 (USD Million)
Table 14 North America Transplant Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 15 U.S. Transplant Diagnostics Market, by Test, 2021-2033 (USD Million)
Table 16 U.S. Transplant Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 17 U.S. Transplant Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 18 U.S. Transplant Diagnostics Market, by Therapeutic Area, 2021-2033 (USD Million)
Table 19 U.S. Transplant Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 20 Canada Transplant Diagnostics Market, by Test, 2021-2033 (USD Million)
Table 21 Canada Transplant Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 22 Canada Transplant Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 23 Canada Transplant Diagnostics Market, by Therapeutic Area, 2021-2033 (USD Million)
Table 24 Canada Transplant Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 25 Mexico Transplant Diagnostics Market, by Test, 2021-2033 (USD Million)
Table 26 Mexico Transplant Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 27 Mexico Transplant Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 28 Mexico Transplant Diagnostics Market, by Therapeutic Area, 2021-2033 (USD Million)
Table 29 Mexico Transplant Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 30 Europe Transplant Diagnostics Market, by Country, 2021-2033 (USD Million)
Table 31 Europe Transplant Diagnostics Market, by Test, 2021-2033 (USD Million)
Table 32 Europe Transplant Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 33 Europe Transplant Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 34 Europe Transplant Diagnostics Market, by Therapeutic Area, 2021-2033 (USD Million)
Table 35 Europe Transplant Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 36 UK Transplant Diagnostics Market, by Test, 2021-2033 (USD Million)
Table 37 UK Transplant Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 38 UK Transplant Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 39 UK Transplant Diagnostics Market, by Therapeutic Area, 2021-2033 (USD Million)
Table 40 UK Transplant Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 41 Germany Transplant Diagnostics Market, by Test, 2021-2033 (USD Million)
Table 42 Germany Transplant Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 43 Germany Transplant Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 44 Germany Transplant Diagnostics Market, by Therapeutic Area, 2021-2033 (USD Million)
Table 45 Germany Transplant Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 46 France Transplant Diagnostics Market, by Test, 2021-2033 (USD Million)
Table 47 France Transplant Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 48 France Transplant Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 49 France Transplant Diagnostics Market, by Therapeutic Area, 2021-2033 (USD Million)
Table 50 France Transplant Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 51 Italy Transplant Diagnostics Market, by Test, 2021-2033 (USD Million)
Table 52 Italy Transplant Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 53 Italy Transplant Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 54 Italy Transplant Diagnostics Market, by Therapeutic Area, 2021-2033 (USD Million)
Table 55 Italy Transplant Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 56 Spain Transplant Diagnostics Market, by Test, 2021-2033 (USD Million)
Table 57 Spain Transplant Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 58 Spain Transplant Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 59 Spain Transplant Diagnostics Market, by Therapeutic Area, 2021-2033 (USD Million)
Table 60 Spain Transplant Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 61 Sweden Transplant Diagnostics Market, by Test, 2021-2033 (USD Million)
Table 62 Sweden Transplant Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 63 Sweden Transplant Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 64 Sweden Transplant Diagnostics Market, by Therapeutic Area, 2021-2033 (USD Million)
Table 65 Sweden Transplant Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 66 Norway Transplant Diagnostics Market, by Test, 2021-2033 (USD Million)
Table 67 Norway Transplant Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 68 Norway Transplant Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 69 Norway Transplant Diagnostics Market, by Therapeutic Area, 2021-2033 (USD Million)
Table 70 Norway Transplant Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 71 Denmark Transplant Diagnostics Market, by Test, 2021-2033 (USD Million)
Table 72 Denmark Transplant Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 73 Denmark Transplant Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 74 Denmark Transplant Diagnostics Market, by Therapeutic Area, 2021-2033 (USD Million)
Table 75 Denmark Transplant Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 76 Asia-Pacific Transplant Diagnostics Market, by Country, 2021-2033 (USD Million)
Table 77 Asia-Pacific Transplant Diagnostics Market, by Test, 2021-2033 (USD Million)
Table 78 Asia-Pacific Transplant Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 79 Asia-Pacific Transplant Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 80 Asia-Pacific Transplant Diagnostics Market, by Therapeutic Area, 2021-2033 (USD Million)
Table 81 Asia-Pacific Transplant Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 82 Japan Transplant Diagnostics Market, by Test, 2021-2033 (USD Million)
Table 83 Japan Transplant Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 84 Japan Transplant Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 85 Japan Transplant Diagnostics Market, by Therapeutic Area, 2021-2033 (USD Million)
Table 86 Japan Transplant Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 87 China Transplant Diagnostics Market, by Test, 2021-2033 (USD Million)
Table 88 China Transplant Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 89 China Transplant Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 90 China Transplant Diagnostics Market, by Therapeutic Area, 2021-2033 (USD Million)
Table 91 China Transplant Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 92 India Transplant Diagnostics Market, by Test, 2021-2033 (USD Million)
Table 93 India Transplant Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 94 India Transplant Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 95 India Transplant Diagnostics Market, by Therapeutic Area, 2021-2033 (USD Million)
Table 96 India Transplant Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 97 Australia Transplant Diagnostics Market, by Test, 2021-2033 (USD Million)
Table 98 Australia Transplant Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 99 Australia Transplant Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 100 Australia Transplant Diagnostics Market, by Therapeutic Area, 2021-2033 (USD Million)
Table 101 Australia Transplant Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 102 Thailand Transplant Diagnostics Market, by Test, 2021-2033 (USD Million)
Table 103 Thailand Transplant Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 104 Thailand Transplant Diagnostics Market, by Therapeutic Area, 2021-2033 (USD Million)
Table 105 Thailand Transplant Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 106 Thailand Transplant Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 107 South Korea Transplant Diagnostics Market, by Test, 2021-2033 (USD Million)
Table 108 South Korea Transplant Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 109 South Korea Transplant Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 110 South Korea Transplant Diagnostics Market, by Therapeutic Area, 2021-2033 (USD Million)
Table 111 South Korea Transplant Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 112 Latin America Transplant Diagnostics Market, by Country, 2021-2033 (USD Million)
Table 113 Latin America Transplant Diagnostics Market, by Test, 2021-2033 (USD Million)
Table 114 Latin America Transplant Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 115 Latin America Transplant Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 116 Latin America Transplant Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 117 Latin America Transplant Diagnostics Market, by Therapeutic Area, 2021-2033 (USD Million)
Table 118 Brazil Transplant Diagnostics Market, by Test, 2021-2033 (USD Million)
Table 119 Brazil Transplant Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 120 Brazil Transplant Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 121 Brazil Transplant Diagnostics Market, by Therapeutic Area, 2021-2033 (USD Million)
Table 122 Brazil Transplant Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 123 Argentina Transplant Diagnostics Market, by Test, 2021-2033 (USD Million)
Table 124 Argentina Transplant Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 125 Argentina Transplant Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 126 Argentina Transplant Diagnostics Market, by Therapeutic Area, 2021-2033 (USD Million)
Table 127 Argentina Transplant Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 128 MEA Transplant Diagnostics Market, by Country, 2021-2033 (USD Million)
Table 129 MEA Transplant Diagnostics Market, by Test, 2021-2033 (USD Million)
Table 130 MEA Transplant Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 131 MEA Transplant Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 132 MEA Transplant Diagnostics Market, by Therapeutic Area, 2021-2033 (USD Million)
Table 133 MEA Transplant Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 134 South Africa Transplant Diagnostics Market, by Test, 2021-2033 (USD Million)
Table 135 South Africa Transplant Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 136 South Africa Transplant Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 137 South Africa Transplant Diagnostics Market, by Therapeutic Area, 2021-2033 (USD Million)
Table 138 South Africa Transplant Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 139 Saudi Arabia Transplant Diagnostics Market, by Test, 2021-2033 (USD Million)
Table 140 Saudi Arabia Transplant Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 141 Saudi Arabia Transplant Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 142 Saudi Arabia Transplant Diagnostics Market, by Therapeutic Area, 2021-2033 (USD Million)
Table 143 Saudi Arabia Transplant Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 144 UAE Transplant Diagnostics Market, by Test, 2021-2033 (USD Million)
Table 145 UAE Transplant Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 146 UAE Transplant Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 147 UAE Transplant Diagnostics Market, by Therapeutic Area, 2021-2033 (USD Million)
Table 148 UAE Transplant Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 149 Kuwait Transplant Diagnostics Market, by Test, 2021-2033 (USD Million)
Table 150 Kuwait Transplant Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 151 Kuwait Transplant Diagnostics Market, by Application, 2021-2033 (USD Million)
Table 152 Kuwait Transplant Diagnostics Market, by Therapeutic Area, 2021-2033 (USD Million)
Table 153 Kuwait Transplant Diagnostics Market, by End Use, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Market summary
Figure 4 Market segmentation & scope
Figure 5 Market size and growth prospects
Figure 6 Transplant Diagnostics Market- Key market driver analysis
Figure 7 Transplant Diagnostics Market - Key market restraint analysis
Figure 8 Penetration & growth prospect mapping
Figure 9 Transplant Diagnostics Market - Porter’s analysis
Figure 10 Transplant Diagnostics Market - PESTEL analysis
Figure 11 Transplant Diagnostics Market Test outlook key takeaways
Figure 12 Transplant Diagnostics Market: Test movement analysis
Figure 13 Molecular Assays Market Estimates, 2021-2033 (USD Million)
Figure 14 PCR-based Molecular Assays Market Estimates, 2021-2033 (USD Million)
Figure 15 Real-time PCR Market estimates, 2021-2033 (USD Million)
Figure 16 Sequence-based Primer-PCR Market Estimates, 2021-2033 (USD Million)
Figure 17 Sequence-specific Oligonucleotide-PCR Market Estimates, 2021-2033 (USD Million)
Figure 18 Other PCR-based Molecular Assays Market Estimates, 2021-2033 (USD Million)
Figure 19 Sequencing-based Molecular Assays Market Estimates, 2021-2033 (USD Million)
Figure 20 Sanger Sequencing Market Estimates, 2021-2033 (USD Million)
Figure 21 Next Generation Sequencing Market Estimates, 2021-2033 (USD Million)
Figure 22 Other Sequencing-based Molecular Assays Market Estimates, 2021-2033 (USD Million)
Figure 23 Non-molecular Assays Market Estimates, 2021-2033 (USD Million)
Figure 24 Serological Assays Market Estimates, 2021-2033 (USD Million)
Figure 25 Mixed Lymphocyte Culture Assays Market Estimates, 2021-2033 (USD Million)
Figure 26 Transplant Diagnostics Market Product Outlook Key Takeaways
Figure 27 Transplant Diagnostics Market: Product Movement Analysis
Figure 28 Reagents & Consumables Market Estimates, 2021-2033 (USD Million)
Figure 29 Instruments Market Estimates, 2021-2033 (USD Million)
Figure 30 Software and Services Market Estimates, 2021-2033 (USD Million)
Figure 31 Transplant Diagnostics Market Application Outlook Key Takeaways
Figure 32 Transplant Diagnostics Market Application Movement Analysis
Figure 33 Diagnostic Application Market Estimates, 2021-2033 (USD Million)
Figure 34 Infectious Disease Testing Market Estimates, 2021-2033 (USD Million)
Figure 35 Histocompatibility Testing Market Estimates, 2021-2033 (USD Million)
Figure 36 Blood Profiling Market Estimates, 2021-2033 (USD Million)
Figure 37 Research Application Market Estimates, 2021-2033 (USD Million)
Figure 38 Transplant Diagnostics Market Transplant Area Outlook Key Takeaways
Figure 39 Transplant Diagnostics Market Transplant Area Movement Analysis
Figure 40 Solid Area Transplantation Market Estimates, 2021-2033 (USD Million)
Figure 41 Kidney Transplantation Market Estimates, 2021-2033 (USD Million)
Figure 42 Liver Transplantation Market Estimates, 2021-2033 (USD Million)
Figure 43 Heart Transplantation Market Estimates, 2021-2033 (USD Million)
Figure 44 Lung Transplantation Market Estimates, 2021-2033 (USD Million)
Figure 45 Pancreas Transplantation Market Estimates, 2021-2033 (USD Million)
Figure 46 Other Organs Transplantation Market Estimates, 2021-2033 (USD Million)
Figure 47 Stem Cell Transplantation Market Estimates, 2021-2033 (USD Million)
Figure 48 Soft Tissue Transplantation Market Estimates, 2021-2033 (USD Million)
Figure 49 Bone Marrow Transplantation Market Estimates, 2021-2033 (USD Million)
Figure 50 Transplant Diagnostics Market End Use Outlook Key Takeaways
Figure 51 Transplant Diagnostics Market End Use Movement Analysis
Figure 52 Hospitals and Transplant Centers Market Estimates, 2021-2033 (USD Million)
Figure 53 Research and Academic Institutes Market Estimates, 2021-2033 (USD Million)
Figure 54 Independent Reference Laboratories Market Estimates, 2021-2033 (USD Million)
Figure 55 Regional marketplace: Key takeaways
Figure 56 Global Transplant Diagnostics Market: Regional movement analysis
Figure 57 North America Transplant Diagnostics Market, 2021-2033 (USD Million)
Figure 58 U.S. Transplant Diagnostics Market, 2021-2033 (USD Million)
Figure 59 Canada Transplant Diagnostics Market, 2021-2033 (USD Million)
Figure 60 Mexico Transplant Diagnostics Market, 2021-2033 (USD Million)
Figure 61 Europe Transplant Diagnostics Market, 2021-2033 (USD Million)
Figure 62 UK Transplant Diagnostics Market, 2021-2033 (USD Million)
Figure 63 Germany Transplant Diagnostics Market, 2021-2033 (USD Million)
Figure 64 France Transplant Diagnostics Market, 2021-2033 (USD Million)
Figure 65 Spain Transplant Diagnostics Market, 2021-2033 (USD Million)
Figure 66 Italy Transplant Diagnostics Market, 2021-2033 (USD Million)
Figure 67 Denmark Transplant Diagnostics Market, 2021-2033 (USD Million)
Figure 68 Sweden Transplant Diagnostics Market, 2021-2033 (USD Million)
Figure 69 Norway Transplant Diagnostics Market, 2021-2033 (USD Million)
Figure 70 Asia-Pacific Transplant Diagnostics Market, 2021-2033 (USD Million)
Figure 71 Japan Transplant Diagnostics Market, 2021-2033 (USD Million)
Figure 72 China Transplant Diagnostics Market, 2021-2033 (USD Million)
Figure 73 India Transplant Diagnostics Market, 2021-2033 (USD Million)
Figure 74 South Korea Transplant Diagnostics Market, 2021-2033 (USD Million)
Figure 75 Australia Transplant Diagnostics Market, 2021-2033 (USD Million)
Figure 76 Thailand Transplant Diagnostics Market, 2021-2033 (USD Million)
Figure 77 Latin America Transplant Diagnostics Market, 2021-2033 (USD Million)
Figure 78 Brazil Transplant Diagnostics Market, 2021-2033 (USD Million)
Figure 79 Argentina Transplant Diagnostics Market, 2021-2033 (USD Million)
Figure 80 MEA Transplant Diagnostics Market, 2021-2033 (USD Million)
Figure 81 South Africa Transplant Diagnostics Market, 2021-2033 (USD Million)
Figure 82 Saudi Arabia Transplant Diagnostics Market, 2021-2033 (USD Million)
Figure 83 UAE Transplant Diagnostics Market, 2021-2033 (USD Million)
Figure 84 Kuwait Transplant Diagnostics Market, 2021-2033 (USD Million)
Figure 85 Strategy framework

Companies Mentioned

The companies profiled in this Transplant Diagnostics market report include:
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • F. Hoffmann La-Roche Ltd
  • Abbott
  • QIAGEN
  • Bruker
  • BD (Becton, Dickinson and Company)
  • Werfen (Immucor, Inc.)
  • Bio-Rad Laboratories, Inc.
  • Omixon Inc.

Table Information

Report AttributeDetails
No. of Pages150
PublishedOctober 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 6.39 Billion
Forecasted Market Value ( USD ) by 2033 $ 12.15 Billion
Compound Annual Growth Rate7.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Transplant Diagnostics Market Report and Forecast 2025-2034 - Product Image

Transplant Diagnostics Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From
Transplant Diagnostics Market Report Size, Share, Trends and Forecast by Component, Technology, Organ Type, Application, End User, and Region, 2025-2033 - Product Image

Transplant Diagnostics Market Report Size, Share, Trends and Forecast by Component, Technology, Organ Type, Application, End User, and Region, 2025-2033

  • Report
  • 148 Pages
  • Global
From
Transplant Diagnostics Market Report 2025 - Product Image

Transplant Diagnostics Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Transplant Diagnostics Market - Global Forecast 2025-2032 - Product Image

Transplant Diagnostics Market - Global Forecast 2025-2032

  • Report
  • 183 Pages
  • Global
From
Transplant Diagnostics - Global Strategic Business Report - Product Image

Transplant Diagnostics - Global Strategic Business Report

  • Report
  • 158 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.